The aromatase inhibitors in early breast cancer: who, when and why?

• Medical and Regulatory Affairs, AstraZeneca Australia, PO Box 131, North Ryde, NSW 1670.

---

• 1. Nordman IC, Spillane AJ, Hamilton AL. The aromatase inhibitors in early breast cancer: who, when and why? Med J Aust 2005; 183: 24-27.<eMJA full text>